5-Fluorouracil ∼99%, pulver
Leverantör: MP Biomedicals
Synonyms:
Fluorouracil, 5-Fluoropyrimidine-2,4(1H,3H)-dione, 5-FU
5-Fluorouracil (5-FU) inhibits the activity of thymidylate synthetase, which affects pyrimidine synthesis and leads to depletion of intracellular TTP pools.
5-FU has also been proposed to interfere with the activity of ribosomal RNA binding protein (RRBP), at the level of pre-ribosomal RNA (pre-rRNA) processing. 5-Fluorouracil is a potent agent against solid tumors that was introduced in 1957 for clinical use. It remains one of the most effective chemotherapeutic agents in such conditions as colorectal cancer, even at its limited response rates (10 to 30%).
A potent antitumor agent that affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. It is metabolized to ribonucleotides and deoxyribonucleotides, which can be incorporated into RNA and DNA. Treatment of cells with 5-FU leads to an accumulation of cells in S-phase and has been shown to induce p53 dependent apoptosis.
Soluble in 1 M Ammonium Hydroxide (50 mg per ml), 1M NaOH and DMSO (10 to 50 mg/ml)/DMF.
Observera: Research Use Only (RUO).
|
Formel:
C₄H₃FN₂O₂ MW: 130,08 g/mol |
MDL Number:
MFCD00006018 CAS nummer: 51-21-8 UN: 2811 ADR: 6.1,III |
Specifikation testresultat
| Identity Test | Passes |
| Purity | ~99% |
| FTIR | Conforms to Standard |
| Melting Point | 278 - 286 °C |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...